Ignite Creation Date:
2025-12-24 @ 11:09 PM
Ignite Modification Date:
2026-02-12 @ 4:17 AM
Study NCT ID:
NCT01820169
Status:
TERMINATED
Last Update Posted:
2016-09-05
First Post:
2013-03-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG
Sponsor:
Hoffmann-La Roche
Organization:
Study Overview
Official Title:
Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG
Status:
TERMINATED
Status Verified Date:
2016-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Only 2 patients screened but none of them were enrolled.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical study is to determine if the use of structured testing, which is a blood glucose monitoring, via the Accu-Chek 360° View blood glucose analysis tool has a positive effect on the subjects overall glycemic control.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: